Light Chain Deposition Disease

hematologic malignancy

Identifier: CI-CAN-00007951
Entity page: /cancer/light-chain-deposition-disease ↗
Edges: 22

Neighbours: 11 drugs10 trials
Drawn: 21 of 21 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Light Chain Deposition Disease investigated in trials for …INVESTIGATED_IN_TRIALSderived11 of 11
→ investigated in trials for	Bortezomibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Light Chain Deposition Disease	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Dexamethasonesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants

Light Chain Deposition Disease studied in …STUDIED_INderived10 of 11show all (up to 200)
→ studied in	NCT05283993recruiting A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT01169337Phase 3 · active not recruiting Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT03820817Phase 1 · completed Rifaximin in Patients With Monoclonal Gammopathy · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT03717844recruiting Registry for Adults With Plasma Cell Disorders (PCD's) · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT00520767Phase 2 · completed Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT01728259Phase 1 · terminated First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT01849783Phase 2 · completed Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT01078454Phase 3 · completed Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT01383759NA · completed Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT01533194Phase 1 · completed Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains